The most significant is a boxed warning from the FDA about a potential risk of thyroid tumors, including a rare type of thyroid cancer called medullary thyroid carcinoma (MTC)
In conclusion, GLP-1 receptor agonists did not increase or decrease the risk of thyroid cancer, hyperthyroidism, hypothyroidism, thyroiditis, thyroid mass and goiter
Reinforce Roots
Shekelle, R
For more information: Othmar Moser, PhD, can be reached at [email protected] or on LinkedIn @OthmarMoser.
Although this has been found to be the case, it was also found that other preprocedural GI effects were observed with a higher incidence in GLP-1 RA users such as reduced gastric acidity, nausea, vomiting, dyspepsia, and abdominal distension (OR 15.1